Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...
Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...
Pfizer's (PFE, Financial) stock experienced a boost on Monday, surging by 3 %, following the news that activist investor ...
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...
The company's latest institutional shareholder has made some troubling allegations against it.
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...